Cocrystal Pharma appoints Gary Wilcox as interim CEO
Dr. Wilcox previously served as the Chief Executive Officer of Cocrystal from 2008 to 2015. Dr. Wilcox will continue to serve as the Vice Chairman of the Board of Directors of the company.
Dr. Wilcox has over 35 years of experience in biotech companies including 14 years at Icos Corporation where he played a key role in the development of Cialis as the Executive Vice President of Operations and a member of the board of directors.
Prior to that, he served as Vice Chairman, Executive Vice President and a Director of Xoma Corporation.
Prior to Xoma, he co-founded Ingene Inc. serving as its Chairman, President and CEO prior to the merger of Ingene into Xoma. Dr. Wilcox was a Professor of Microbiology and a member of the Molecular Biology Institute at UCLA for 10 years.
He has served on 15 boards of directors including NASDAQ, New York and London stock exchange companies, as well as private technology companies.
In addition, Dr. Douglas Mayers, the Chief Medical Officer at Cocrystal, submitted his resignation.
Dr. Luz Pascual, Vice President Clinical Development, shall continue to oversee the ongoing clinical programs. ■
LATEST MOVES FROM Washington
- HaloSource appoints Craig Crowell to board as CFO
- Esterline appoints Michael J. Covey to board
- First Sound Bank promotes Lisa Cleary to EVP
- Nordstrom appoints Anne Bramman as CFO
- Timberland Bancorp appoints James A. Davis to board
More inside POST
RWE Q1 net income increased 10% Earnings